Abstract
摘要
相似文献
1
Exenatide: excessive weight loss.
Prescrire Int. 2011 Jan;20(112):17.
2
Exenatide (Byetta) for type 2 diabetes.艾塞那肽（百泌达）用于2型糖尿病。
Med Lett Drugs Ther. 2005 Jun 6;47(1210):45-6.
3
Exenatide and rare adverse events.艾塞那肽与罕见不良事件。
N Engl J Med. 2008 May 1;358(18):1970-1; discussion 1971-2.
4
Byetta update: what we've learned from experience.
Diabetes Self Manag. 2010 Mar-Apr;27(2):28, 30-1.
5
Use of exenatide for weight loss in patients with diabetes.艾塞那肽在糖尿病患者体重减轻中的应用。
Am Fam Physician. 2007 May 1;75(9):1304.
6
[Exenatide--an alternative to insulin in the treatment of type 2 diabetes?].[艾塞那肽——治疗2型糖尿病时胰岛素的替代药物？]
Ugeskr Laeger. 2008 Sep 22;170(39):3039-43.
7
Exenatide and acute pancreatitis.艾塞那肽与急性胰腺炎
J Assoc Physicians India. 2008 Dec;56:987-8.
8
Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes.艾塞那肽长效释放制剂每周一次给药对2型糖尿病患者血糖控制和体重的影响。
Diabetes Care. 2007 Jun;30(6):1487-93. doi: 10.2337/dc06-2375. Epub 2007 Mar 12.
9
Summaries for patients. Exenatide therapy for type 2 diabetes.患者摘要。艾塞那肽治疗2型糖尿病。
Ann Intern Med. 2007 Apr 3;146(7):I18. doi: 10.7326/0003-4819-146-7-200704030-00002.
10
Addition of thiazolidinedione or exenatide to oral agents in type 2 diabetes: a meta-analysis.在2型糖尿病口服药物治疗中添加噻唑烷二酮类药物或艾塞那肽：一项荟萃分析。
Ann Pharmacother. 2008 Nov;42(11):1541-51. doi: 10.1345/aph.1L198. Epub 2008 Oct 28.
Zotero 插件